Literature DB >> 2453545

Allergic rhinitis: mechanisms and management.

B A Berman.   

Abstract

Allergic rhinitis is a multifactorial disease that often requires a multimodal treatment program. Most medications, studied individually, demonstrate only a 50% reduction of specific symptoms. Antihistaminics, including the newer generation of nonsedative agents, decongestants, cromolyn sodium, topical synthetic corticosteroids, and orally administered delta-1 steroids, are the commonly prescribed medications used alone or in various combinations. Cromolyn sodium, with its novel mechanism of action and remarkable safety record, is ideally suitable for preventing symptoms resulting from allergic challenge and for substantially reducing symptoms after exposure.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2453545     DOI: 10.1016/0091-6749(88)90165-0

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  3 in total

Review 1.  Economic outcomes for the treatment of allergic rhinitis.

Authors:  C M Kozma; M K Sadik; M L Watrous
Journal:  Pharmacoeconomics       Date:  1996-07       Impact factor: 4.981

2.  Randomised controlled trial of butterbur and cetirizine for treating seasonal allergic rhinitis.

Authors:  Andreas Schapowal
Journal:  BMJ       Date:  2002-01-19

Review 3.  Years in Review: Recent Progress in Cellular Allergology.

Authors:  Bernhard Kratzer; Winfried F Pickl
Journal:  Int Arch Allergy Immunol       Date:  2016-03-09       Impact factor: 2.749

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.